O=C(NCC1CCCO1)C(c1ccc(F)cc1)N(CC1CCCO1)C(=O)c1ccc(-c2ccccc2)[nH]1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?